Given the upregulation of LINC01094 in CRC, LINC01094 si-RNA and miR-1266-5p inhibitor were used to moderate the expression of miR-1266-5p (P < 0.01, Figure 5a). This evidence concerns the gene LINC01094 and colorectal carcinoma.